Literature DB >> 20490818

Supracricoid laryngectomy: oncologic validity and functional safety.

Kwang Jae Cho1, Young Hoon Joo, Dong Il Sun, Min Sik Kim.   

Abstract

The objectives of this study are to elucidate the oncologic validity of the supracricoid laryngectomy (SCL) for locally advanced endolaryngeal cancers and as a salvage procedure, and to determine its safety in maintaining laryngeal physiology. The medical records of 114 patients that underwent SCL were reviewed. We examined whether the extended procedures, salvage procedure, adjuvant treatment, and type of reconstruction were associated with patient survival and the mean time of decannulation and nasogastric tube removal. Postoperative complications were investigated. There was no significant difference in survival according to the extent of the resection of the primary tumors and the presence or absence of previous treatment. However, the survival of patients that received radiation or concurrent chemoradiation after SCL was significantly lower than that of patients without any adjuvant treatment. Decannulation and nasogastric tube removal was possible for all except for two patients, and the mean time required was 18.4 and 26.1 days, respectively. The interval to starting oral feeding was significantly increased in cases that underwent cricohyoidopexy, an extended procedure, and salvage surgery compared to their counterparts. Pulmonary complications, particularly aspiration pneumonia, were the most common postoperative complications. The results of this study suggest that SCL was feasible for locally advanced laryngeal cancers and as a salvage procedure. Active and effective postoperative swallowing rehabilitation, particularly in cases that underwent cricohyoidopexy, an extended procedure, and salvage surgery, is needed to prevent aspiration pneumonia.

Entities:  

Mesh:

Year:  2010        PMID: 20490818     DOI: 10.1007/s00405-010-1279-y

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN: 0937-4477            Impact factor:   2.503


  21 in total

Review 1.  Supracricoid laryngectomy: is it time to define guidelines to evaluate functional results? a review.

Authors:  Gino Marioni; Rosario Marchese-Ragona; Giancarlo Ottaviano; Alberto Staffieri
Journal:  Am J Otolaryngol       Date:  2004 Mar-Apr       Impact factor: 1.808

Review 2.  Supracricoid partial laryngectomy: an organ-preservation surgery for laryngeal malignancy.

Authors:  F Christopher Holsinger; Gregory S Weinstein; Ollivier Laccourreye
Journal:  Curr Probl Cancer       Date:  2005 Jul-Aug       Impact factor: 3.187

3.  Prognostic role of pneumonia in supracricoid and supraglottic laryngectomies.

Authors:  O Gallo; A Deganello; G Gitti; R Santoro; M Senesi; J Scala; V Boddi; E De Campora
Journal:  Oral Oncol       Date:  2008-07-11       Impact factor: 5.337

4.  Supracricoid partial laryngectomy as salvage surgery for radiation therapy failure.

Authors:  Alberto Deganello; Oreste Gallo; Jano Maria De Cesare; Maria Benedetta Ninu; Gianni Gitti; Luca de' Campora; Marco Radici; Enrico de' Campora
Journal:  Head Neck       Date:  2008-08       Impact factor: 3.147

5.  Complications and functional outcome after supracricoid partial laryngectomy with cricohyoidoepiglottopexy.

Authors:  P Naudo; O Laccourreye; G Weinstein; V Jouffre; H Laccourreye; D Brasnu
Journal:  Otolaryngol Head Neck Surg       Date:  1998-01       Impact factor: 3.497

6.  Deglutition after supracricoid laryngectomy: compensatory mechanisms and sequelae.

Authors:  V Woisard; M Puech; E Yardeni; E Serrano; J J Pessey
Journal:  Dysphagia       Date:  1996       Impact factor: 3.438

7.  Surgery and postoperative radiotherapy for squamous cell carcinoma of the larynx and pharynx.

Authors:  Russell W Hinerman; Christopher G Morris; Robert J Amdur; Christopher D Lansford; John W Werning; Douglas B Villaret; William M Mendenhall
Journal:  Am J Clin Oncol       Date:  2006-12       Impact factor: 2.339

8.  Supracricoid laryngectomy with cricohyoidopexy: a partial laryngeal procedure for selected supraglottic and transglottic carcinomas.

Authors:  H Laccourreye; O Laccourreye; G Weinstein; M Menard; D Brasnu
Journal:  Laryngoscope       Date:  1990-07       Impact factor: 3.325

9.  Extended supracricoid laryngectomy with excision of both arytenoids: the modified reconstructive laryngectomy.

Authors:  Mohamed Rifai
Journal:  Acta Otolaryngol       Date:  2007-06       Impact factor: 1.494

10.  Role of the modified barium swallow in management of patients with dysphagia.

Authors:  J A Logemann
Journal:  Otolaryngol Head Neck Surg       Date:  1997-03       Impact factor: 5.591

View more
  6 in total

Review 1.  Conservative treatment for advanced T3-T4 laryngeal cancer: meta-analysis of key oncological outcomes.

Authors:  Giuditta Mannelli; Maria Silvia Lazio; Paolo Luparello; Oreste Gallo
Journal:  Eur Arch Otorhinolaryngol       Date:  2017-11-08       Impact factor: 2.503

2.  Supracricoid laryngectomy with cricohyoidopexy: oncological results.

Authors:  Ilhan Topaloğlu; Muhlis Bal; Ziya Salturk
Journal:  Eur Arch Otorhinolaryngol       Date:  2011-12-01       Impact factor: 2.503

3.  Supracricoid laryngectomies: oncological and functional results for 152 patients.

Authors:  C A Leone; P Capasso; G Russo; P D'Errico; P Cutillo; P Orabona
Journal:  Acta Otorhinolaryngol Ital       Date:  2014-10       Impact factor: 2.124

Review 4.  Supracricoid laryngectomy for recurrent laryngeal cancer after chemoradiotherapy: a systematic review and meta-analysis.

Authors:  C A Leone; P Capasso; D Topazio; G Russo
Journal:  Acta Otorhinolaryngol Ital       Date:  2016-12       Impact factor: 2.124

Review 5.  Oncological Outcomes of Primary vs. Salvage OPHL Type II: A Systematic Review.

Authors:  Carmelo Saraniti; Barbara Verro; Francesco Ciodaro; Francesco Galletti
Journal:  Int J Environ Res Public Health       Date:  2022-02-06       Impact factor: 3.390

6.  Relationship between preepiglottic space invasion and lymphatic metastasis in supracricoid partial laryngectomy with cricohyoidopexy.

Authors:  Young-Hoon Joo; Jun-Ook Park; Kwang-Jae Cho; Min-Sik Kim
Journal:  Clin Exp Otorhinolaryngol       Date:  2014-08-01       Impact factor: 3.372

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.